Revvity Q1 2026 Earnings Solid EPS Beat Amidst Cost Discipline NuCana Q3 2024 Earnings SmallerthanExpected Loss as Biotech Advances Oncology Pipeline FAF Q1 2026 Earnings EPS Beat by 256 Despite Mixed Market Reaction WIMI Q4 2020 Earnings EPS Misses Estimates Amid Slight Stock Decline CDP Q1 2026 Earnings EPS Surpasses Estimates with 2 Beat CPHC Q2 2025 Earnings Net Loss Per Share of 006 Reported Stock Edges Higher